Partner Content

Oncology
8th Tumor Models San Francisco Summit 2024
Partner Content

8th Tumor Models San Francisco Summit 2024

Following Merck announcing their goal to phase out animal use in their work, Astellas and MIMETAS expanding their partnership in immunotherapeutic development, and the domino effects across the fie

Oncology
3rd Annual Tumor-Myeloid-Directed Therapies Summit
Partner Content

3rd Annual Tumor-Myeloid-Directed Therapies Summit

Activating the myeloid compartment to tackle tumor suppression. Benchmark Novel Targets, Identify Appropriate Biomarkers & Unravel Myeloid Biology to Accelerate Clinical Translation of Myeloid-Targeted Combination Approaches.